Search results

...osphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET capacity| ET state]] is evaluated.

...] in [[LEAK respiration#The_LEAK_state |LEAK state]] and [[ET capacity| ET state]] is evaluated.

[[OXPHOS capacity]] ''P'' (with saturating [ADP]), active OXPHOS state.

...osphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET capacity| ET state]] is evaluated.

...osphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET capacity| ET state]] can be evaluated. SUIT-015 O2 pti D043 can be extended with the CIV assay

...are designed to measure simultaneously O₂ flux and the Q-redox state in isolated mitochondria and permeabilized cells.

...rylation|OXPHOS state]] and [[FN]], [[FNS]] and [[S]] in [[ET capacity| ET state]].

...are designed to measure simultaneously O₂ flux and the Q-redox state in isolated mitochondria and permeabilized cells.

...naplerosis|anaplerotic]] pathways. Moreover, the pathway control in OXPHOS state ([[Fatty_acid_oxidation_pathway_control_state|F]], F(N), [[FN]], [[FNS]], p

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol. SUIT-002 pfi D006 can

| ([[Malate-anaplerotic pathway control state|M]]_{[[LEAK respiration|''L'']]}) | ([[Malate-anaplerotic pathway control state| M]]_{[[OXPHOS|''P'']]})

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol.

...EAK component of respiration, ''L_P'', as measured in the OXPHOS state, particularly if the protonmotive force is not adjusted to equivalent level ::::* Expand Bioblast links to '''''P-L'' net OXPHOS capacity'''

...and ET state ([[NS-pathway control state|NS]], [[Succinate pathway control state|S]]) is also evaluated, covering the contribution of two pathways which are

...on_pathway_control_state|F]], F(N), [[FN]] and [[FNS]] pathways) and in ET state ([[FNS]] and [[S]]) can be evaluated by using this SUIT protocol.

'''MitoPathway control state:''' [[FN]] |mitopedia concept=SUIT state

'''MitoPathway control state:''' [[FNS]] |mitopedia concept=SUIT state

...ET state ([[NS-pathway control state|NS]] and [[Succinate pathway control state|S]]). SUIT-011 can be extended with the CIV assay module.

'''MitoPathway control state:''' [[FN]] |mitopedia concept=SUIT state

::::::» [[Coupling control state]] ::::::» [[OXPHOS capacity]]

'''MitoPathway control state:''' [[ F | Fatty acid oxidation pathway control state]] |mitopedia concept=SUIT state

| ([[Malate-anaplerotic pathway control state|M]]_{[[LEAK|''L'']]}) | ([[Malate-anaplerotic pathway control state| M]]_{[[OXPHOS|''P'']]})

| [[Fatty acid oxidation pathway control state| F(N)]] | [[PalM]]_{''[[OXPHOS|P]]''}

'''MitoPathway control state:''' [[ F | Fatty acid oxidation pathway control state]] |mitopedia concept=SUIT state

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol.

| [[Fatty acid oxidation pathway control state| F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}

...is present in the sample studied ([[Glutamate-anaplerotic pathway control state]]). | [[Glutamate|G]]_{''[[OXPHOS|P]]''}

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol. SUIT-002 O2 mt D005 ca

...is present in the sample studied ([[Glutamate-anaplerotic pathway control state]]). | [[Glutamate|G]]_{''[[OXPHOS|P]]''}

...for studying a particular respiratory state? Example: [[OXPHOS]] capacity, state ''P''. ...s of ADP, P_i, and O₂ to verify that OXPHOS capacity, state ''P'', rather than a substrate-limited flux is measured.

'''MitoPathway control state:''' NSGp OctPGMSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:

'''MitoPathway control state:''' FNSGp OctPGMSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:

...ontrol_state|F]], F(N), [[FN]], [[FNS]] pathways) and in [[ET capacity| ET state]] ([[FNS]] and [[S]]) can be evaluated by using this SUIT protocol.

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol. SUIT-002 O2 ce-pce D00

'''MitoPathway control state:''' [[FN]] ...e is added to compare FAO as the background state with FN as the reference state.

'''MitoPathway control state:''' [[FN]] ...e is added to compare FAO as the background state with FN as the reference state.

::::::» [[Coupling-control state]] ::::::» [[Electron-transfer-pathway state]]

::: '''[[Coupling-control state]]''' :::: [[Image:P.jpg|link=OXPHOS capacity|OXPHOS]] [[Image:R.jpg|link=ROUTINE respiration|ROUTINE]] [[Image:E.jpg|link=ET ca

! Respiratory state | [[OXPHOS-coupling efficiency]] in state F.

...substrate combinations ([[PM-pathway control state]], [[GM-pathway control state]]). ...alate-anaplerotic pathway (malate alone in the presence of ADP) and OXPHOS state (''P'') with pyruvate&malate and pyruvate&glutamate&malate as NADH-linked s

| [[Fatty acid oxidation pathway control state|F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}

| [[Fatty acid oxidation pathway control state| F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol.

...ays) and in [[ET capacity| ET state]] ([[FNSGp]] and [[SGp-pathway control state|SGp]]) can be evaluated by using this SUIT protocol.

| [[Fatty acid oxidation pathway control state| F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}

...corresponding coupled respiration is the [[free OXPHOS capacity]]. In the state of ROUTINE respiration, coupled respiration is the [[free ROUTINE activity]

'''MitoPathway control state:''' [[FNS]] OctGMS pathway in the LEAK state can be evaluated in the following SUIT protocols:

| [[Fatty acid oxidation pathway control state|F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}

| [[Fatty acid oxidation pathway control state| F(N)]] | [[OctM]]_{''[[OXPHOS|P]]''}